Ljungman Lisa, Anandavadivelan Poorna, Jahnukainen Kirsi, Lampic Claudia, Wettergren Lena
Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Division of Haematology-Oncology and Stem Cell Transplantation, Children's Hospital, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland.
Medicine (Baltimore). 2020 Jul 10;99(28):e19919. doi: 10.1097/MD.0000000000019919.
This study protocol describes the Fex-Can Childhood project, comprising two studies: The Fex-Can Childhood observational study (OS) and the Fex-Can Childhood randomized controlled trial (RCT). The Fex-Can Childhood OS aims to determine the prevalence and predictors of sexual dysfunction and fertility-related distress in young adult childhood cancer survivors (aged 19-40) compared to an age matched comparison group; the Fex-Can Childhood RCT will evaluate the effect of a web-based psycho-educational intervention (Fex-Can intervention) on sexual dysfunction and fertility-related distress.
The Fex-Can Childhood OS will have a population-based cross-sectional design. All individuals treated for childhood cancer in Sweden at the age of 0 to 17 years (current age 19-40) will be identified through the National Quality Registry for Childhood Cancer. Established self-reported instruments will be used to measure sexual function, fertility-related distress, body image, anxiety and depression, and health-related quality of life. Self-efficacy related to sexual function and fertility, and fertility-related knowledge, will be assessed by study-specific measures. Clinical variables will be collected from the registry. Results will be compared to an age-matched comparison group from the general population.Participants in the Fex-Can Childhood OS who report a high level of sexual dysfunction and/or fertility-related distress will be invited to participate in the RCT. The Fex-Can intervention comprises two programs: The Fex-Can Sex and the Fex-Can Fertility targeting sexual dysfunction and fertility-related distress, respectively. The control condition will be a wait-list. Sexual function and fertility-related distress will be the primary outcomes. The secondary outcomes include body image, anxiety and depression, health-related quality of life and self-efficacy related to sexual function and fertility. Post- and follow-up assessments will be conducted directly after end of intervention (primary end point), at 3 months and 6 months after end of intervention. Additionally, a process-evaluation including study-specific items and a qualitative interview will be conducted.
The Fex-Can Childhood project will advance knowledge in the areas of sexual function and fertility-related distress among young adult survivors of childhood cancer. If the Fex-Can intervention proves to be efficacious, steps will be taken to implement it in the follow-up care provided to this population.
本研究方案描述了“Fex-Can儿童项目”,该项目包括两项研究:Fex-Can儿童观察性研究(OS)和Fex-Can儿童随机对照试验(RCT)。Fex-Can儿童OS旨在确定与年龄匹配的对照组相比,年轻成年期儿童癌症幸存者(19 - 40岁)性功能障碍和生育相关困扰的患病率及预测因素;Fex-Can儿童RCT将评估基于网络的心理教育干预(Fex-Can干预)对性功能障碍和生育相关困扰的影响。
Fex-Can儿童OS将采用基于人群的横断面设计。瑞典所有0至17岁(当前年龄19 - 40岁)接受过儿童癌症治疗的个体将通过国家儿童癌症质量登记处进行识别。将使用既定的自我报告工具来测量性功能、生育相关困扰、身体形象、焦虑和抑郁以及健康相关生活质量。与性功能和生育相关的自我效能感以及生育相关知识将通过特定研究措施进行评估。临床变量将从登记处收集。结果将与来自一般人群的年龄匹配对照组进行比较。Fex-Can儿童OS中报告性功能障碍和/或生育相关困扰程度较高的参与者将被邀请参加RCT。Fex-Can干预包括两个项目:分别针对性功能障碍和生育相关困扰的Fex-Can性健康项目和Fex-Can生育项目。对照条件将是等待名单。性功能和生育相关困扰将是主要结局。次要结局包括身体形象、焦虑和抑郁、健康相关生活质量以及与性功能和生育相关的自我效能感。干预结束后(主要终点)、干预结束后3个月和6个月将直接进行干预后评估和随访评估。此外,将进行包括特定研究项目和定性访谈的过程评估。
Fex-Can儿童项目将推进有关儿童癌症年轻成年幸存者性功能和生育相关困扰领域的知识。如果Fex-Can干预被证明有效,将采取措施在为该人群提供的后续护理中实施。